[Psychedelics in the field of chronic pain. A path to explore?].
Revue medicale suisse February 14, 2024 Aude Molinard-Chenu, Georgios Tsimploulis, Louise Penzenstadler et al.
Psychedelics are being investigated as a new therapeutic approach for chronic pain. They can influence the serotonergic system, which affects central pain sensitization. Ketamine, already used for chronic pain, can reduce pain, but more studies are needed on its long-term effectiveness. Classic psychedelics are also drawing interest for their potential analgesic, anti-inflammatory, and functional effects, though research is limited. These findings encourage further investigation.